These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 6428496)
1. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice. Boden R; Botting R; Coulson P; Spanswick G Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496 [TBL] [Abstract][Full Text] [Related]
2. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline. Todd KG; Baker GB J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840 [TBL] [Abstract][Full Text] [Related]
3. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline. Sivam SP Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341 [TBL] [Abstract][Full Text] [Related]
4. Modification by monoamine oxidase inhibitors of the analgesic, hypothermic and toxic actions of morphine and pethidine in mice. Botting R; Bower S; Eason CT; Hutson PH; Wells L J Pharm Pharmacol; 1978 Jan; 30(1):36-40. PubMed ID: 22722 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477 [TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Celada P; Artigas F Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703 [TBL] [Abstract][Full Text] [Related]
7. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat. Rényi L Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132 [TBL] [Abstract][Full Text] [Related]
8. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl]. Severina IS Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561 [TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium. Lenzen S; Nahrstedt H; Panten U Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132 [TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity. Seymour CB; Mothersill C; Mooney R; Moriarty M; Tipton KF Br J Cancer; 2003 Nov; 89(10):1979-86. PubMed ID: 14612913 [TBL] [Abstract][Full Text] [Related]
11. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system. Blier P; De Montigny C; Azzaro AJ J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685 [TBL] [Abstract][Full Text] [Related]
12. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue. Azzaro AJ; Amedro JB; Brown LM; Smith DJ; Williams GM Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):9-13. PubMed ID: 2467212 [TBL] [Abstract][Full Text] [Related]
13. Properties of monoamine oxidase in monkey heart. Katayama M; Kobayashi S; Oguchi K; Yasuhara H Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of [3H]5-hydroxytryptamine binding sites in chick embryo brain by monoamine oxidase inhibitors or fenfluramine and potentiation by d,l-5-hydroxytryptophan. Soblosky JS; DuMontier G; Jeng I J Neurochem; 1985 Dec; 45(6):1923-31. PubMed ID: 3932597 [TBL] [Abstract][Full Text] [Related]
15. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan. Sleight AJ; Marsden CA; Martin KF; Palfreyman MG Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963 [TBL] [Abstract][Full Text] [Related]
16. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats. Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145. Azam M; Jain S; Baquer NZ Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104 [TBL] [Abstract][Full Text] [Related]
18. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues. Celada P; Artigas F J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085 [TBL] [Abstract][Full Text] [Related]
19. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Green AR; Youdim MB Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627 [TBL] [Abstract][Full Text] [Related]
20. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum. Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]